Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Brain study may lead to new treatments for neuro-immune conditions

The immune system is the brain's best frenemy. It protects the brain from infection and helps injured tissues heal, but it also causes autoimmune diseases and creates inflammation that drives neurodegeneration.

8 Jun 2021

Researchers uncover molecular mechanism linking Parkinson’s disease with COVID-19

The study findings reveal that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection results in abnormal modification of some lung proteins, which are subsequently transported to the brain via exosomes. In the brain, these modified lung proteins disrupt the normal functioning of proteins that are related to Parkinson’s disease.

7 Jun 2021

MRI-guided focused ultrasound advances brain and cancer research

By 2034, nearly one-quarter of Americans will have reached retirement age, according to the United States Census Bureau. But as people age, the brain becomes more susceptible to developing disorders, such as essential tremor, Parkinson's disease, and tumors.

7 Jun 2021

New algorithm could be an important step toward adaptive deep brain stimulation

By delivering small electrical pulses directly to the brain, deep brain stimulation (DBS) can ease tremors associated with Parkinson's disease or help relieve chronic pain.

1 Jun 2021

Nanoscale coordination polymers show promise for efficient dopamine delivery in Parkinson's treatment

Parkinson's disease (PD) is a common neurodegenerative disorder caused by the death of dopaminergic neurons in a part of the brain (known as substantia nigra pars compacta), which leads to a deficit of dopamine (DA), one of the main neurotransmitters active in the central nervous system.

1 Jun 2021

Study reveals potential mechanism for how traumatic brain injury leads to neurodegenerative diseases

Scientists have revealed a potential mechanism for how traumatic brain injury leads to neurodegenerative diseases, according to a study in fruit flies, and rat and human brain tissue, published today in eLife.

1 Jun 2021

New initiative to reduce treatment delays for patients with rare diseases

The Treatabolome project is a research initiative to develop a freely available, interoperable online platform dedicated to disseminating rare disease and gene-specific treatment information to healthcare professionals regardless of their level of specialized expertise.

1 Jun 2021

New project aims to validate digital biomarkers for better treatment of Parkinson's disease

Parkinson's disease affects seven to ten million patients in Western societies - with an upward trend. Patients suffer from symptoms such as tremors, gait and speech disorders, and memory loss.

31 May 2021

New brain stimulation technique precisely controls motor activity without surgical device implantation

Neurological disorders such as Parkinson's disease and epilepsy have had some treatment success with deep brain stimulation, but those require surgical device implantation.

29 May 2021

Study may help devise new therapies, improve quality of life for Parkinson's patients

A new discovery by University of Guelph researchers may ultimately help in devising new therapies and improving quality of life for people with Parkinson's disease.

27 May 2021

Researchers identify structure of agent that causes Alzheimer's and Parkinson's diseases

Alzheimer's disease - also called dementia - where memory and cognitive functions gradually decline due to deformation and death of neurons, and Parkinson's disease that causes tremors in hands and arms impeding normal movement are major neurodegenerative diseases.

26 May 2021

Altered blood flow in the brain may cause symptoms of Parkinson's disease

Patients who suffer from REM sleep behavior disorder have altered blood flow in the brain, which can lead to a lack of oxygen in the brain tissue. In the long term, this may cause symptoms of Parkinson's disease. This is shown by research from Aarhus University and Aarhus University Hospital.

26 May 2021

New technology makes it easier to diagnose neurodegenerative diseases

A new combination of optical coherence tomography (OCT), adaptive optics and deep neural networks should enable better diagnosis and monitoring for neuron-damaging eye and brain diseases like glaucoma.

25 May 2021

New gel could be used as nasal spray for treating Parkinson's patients

Scientists at the University of York have made significant progress in the development of a nasal spray treatment for patients with Parkinson's disease.

25 May 2021

Researchers develop integrative approach to better understand the origins of Parkinson's disease

Parkinson's disease is the second most common neurodegenerative disease and affects more than 10 million people around the world.

19 May 2021

A look at how coronavirus disease (COVID-19) affects Parkinson's

Earlier, herpes simplex virus (HSV), influenza virus A, measles virus, cytomegalovirus (CMV), and mumps virus have all been associated with after-effects of the virus that includes Parkinson's disease (PD). This list may now include SARS-CoV-2.

14 May 2021

Reversible pharmacological treatment can improvise stuttering in humans

Speech problems such as stammering or stuttering plague millions of people worldwide, including 3 million Americans.

11 May 2021

New implantable system can manipulate brain signals and suppress pathological coupling

As researchers learn more about the brain, it has become clear that responsive neurostimulation is becoming increasingly effective at probing neural circuit function and treating neuropsychiatric disorders, such as epilepsy and Parkinson's disease.

10 May 2021

Brain-targeting drug delivery with nano-scaled apoptotic bodies

Scientists from Nanjing University and University of Macau have discovered nano-scaled apoptotic bodies (ABs) as a new brain-targeting drug carrier, bringing new promise for the Parkinson's Disease as well as other brain diseases.

7 May 2021

Defective epithelial barrier responsible for up to two billion chronic diseases

Humans are exposed to a variety of toxins and chemicals every day. According to the epithelial barrier hypothesis, exposure to many of these substances damages the epithelium, the thin layer of cells that covers the surface of our skin, lungs and intestine. Defective epithelial barriers have been linked to a rise in almost two billion allergic, autoimmune, neurodegenerative and psychiatric diseases.

6 May 2021

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Brain study may lead to new treatments for neuro-immune conditions

Researchers uncover molecular mechanism linking Parkinson’s disease with COVID-19

MRI-guided focused ultrasound advances brain and cancer research

New algorithm could be an important step toward adaptive deep brain stimulation

Nanoscale coordination polymers show promise for efficient dopamine delivery in Parkinson's treatment

Study reveals potential mechanism for how traumatic brain injury leads to neurodegenerative diseases

New initiative to reduce treatment delays for patients with rare diseases

New project aims to validate digital biomarkers for better treatment of Parkinson's disease

New brain stimulation technique precisely controls motor activity without surgical device implantation

Study may help devise new therapies, improve quality of life for Parkinson's patients

Researchers identify structure of agent that causes Alzheimer's and Parkinson's diseases

Altered blood flow in the brain may cause symptoms of Parkinson's disease

New technology makes it easier to diagnose neurodegenerative diseases

New gel could be used as nasal spray for treating Parkinson's patients

Researchers develop integrative approach to better understand the origins of Parkinson's disease

A look at how coronavirus disease (COVID-19) affects Parkinson's

Reversible pharmacological treatment can improvise stuttering in humans

New implantable system can manipulate brain signals and suppress pathological coupling

Brain-targeting drug delivery with nano-scaled apoptotic bodies

Defective epithelial barrier responsible for up to two billion chronic diseases

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in